Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in a Recent Idiopathic Pulmonary Fibrosis Study by 56%

Stock Information for Algernon Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.